KHRNF OTC
Khiron Life Sciences Corp.
1W: +900.0%
1M: +900.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$20M
+16.8% ▲
Capital Expenditures
$2M
+35.2% ▲
Free Cash Flow
-$22M
+18.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$13M
-203.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$45K | -$20M | -$36M | -$24M | -$34M |
| Depreciation & Amort. | $0 | $338K | $939K | $1M | $1M |
| Stock-Based Comp. | $0 | $0 | $9K | $6M | $2M |
| Change in Working Capital | $23K | $1M | -$3M | -$2M | -$2M |
| Other Non-Cash Items | $0 | $0 | $9M | -$6M | $12M |
| Operating Cash Flow | -$21K | -$15M | -$30M | -$25M | -$20M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$4M | -$6M | -$3M | -$2M |
| Acquisitions (Net) | $0 | -$1M | -$3M | $0 | -$342 |
| Investment Purchases | $0 | -$4M | -$23M | $0 | $0 |
| Investment Sales | $0 | $0 | $23M | $28M | $0 |
| Other Investing | $0 | $0 | -$23M | $0 | -$342K |
| Investing Cash Flow | $0 | -$9M | -$32M | $25M | -$2M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | -$1M | -$555 | -$107K |
| Stock Repurchased | $0 | $0 | $0 | -$212K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $5K | $15M | $5M | $12M | $0 |
| Financing Cash Flow | $5K | $38M | $57M | $12M | $11M |
| Net Change in Cash | -$16K | $13M | -$6M | $12M | -$13M |
| Cash End of Period | $5K | $15M | $9M | $22M | $9M |
| Free Cash Flow | -$21K | -$19M | -$36M | -$27M | -$22M |